AstraZeneca announces surprise U-turn with plan to inject Britain with massive £300m splurge

1 sources1 storiesFirst seen 4/30/2026Score24Mixed Progress

Single Source

Bigness

Coverage

Recency

Engagement

Velocity

Confidence

Clipability

Polarization

Claims

Contradictions

Breakthrough

Sentiment Mix

Positive100%

Neutral0%

Negative0%

Geography

EuropeNorth America

Expert Signals

GB News - News

source • 1 mention

AI-Generated Claims

Generated from linked receipts; click sources for full context.

AstraZeneca announces surprise U-turn with plan to inject Britain with massive £300m splurge.

Supported by 1 story

AstraZeneca has announced a surprise U-turn on investment into the UK - and will press ahead with a major £300million spend.The pharmaceutical giant last year paused a planned £200million expansion of its research site in Cambridge, and scrapped plans to invest £450million in a Merseyside vaccine plant.In February 2025, AstraZeneca chief executive Pascal Soriot said the firm "couldn't make the business case work and couldn't make the investment economically viable".But after a trade deal with the US was finalised earlier this month, UK pharmaceutical exports will be exempt from American tariffs.

Supported by 1 story

TRENDING Stories Videos Your Say Britain has also pledged to double spending on innovative medicines from 0.3 per cent to 0.6 per cent of GDP.Today, Mr Soriot thanked the Government for its "efforts to improve access for patients".In addition, the thresholds at which the National Institute for Health and Care Excellence (Nice) judged medicine to be cost-effective for NHS use has improved.Sir...

Supported by 1 story